The Clostridioides Difficile Trial of REC-3964

Clinical trial NCT06536465 · TERMINATED

Trial details

NCT number: NCT06536465
Sponsor: Recursion Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Clostridioides Difficile Infection

Start date: 2024-10-14
Primary completion: 2025-05-06
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.